Tag: SPY

Blue Horseshoe Stocks: SNTA Recap, Options & More

Synta Pharmaceuticals Corp. SNTA

After catching a PR containing some big merger news for SNTA yesterday morning, we decided to include the stock in our premarket report, and it turned out to be a good decision.

On just under 12X the 3-month average trading volume, SNTA ran from a daily low of .32 up to .45 inside of the first 90 minutes of the session. That registered as a respectable intraday spike of 41% As measured to this morning’s premarket high of .488, that figure is extended to 53%

We’ll have our eyes peeled for another push this morning. The type of volume that we witnessed yesterday coupled with the stock holding more than 50% of its daily gains, puts SNTA into the category of a possible momentum play.

______

Bonus Pharma Watchlist:

We are also going to be monitoring the activity in a couple of other pharma stocks in coming sessions:  Aoxing Pharmaceutical Co., Inc. AXN and Eleven Biotherapeutics, Inc. EBIO

EBIO is reportedly another reverse-merger candidate that caught a wave of momentum on the heels of yesterday’s big news, and AXN is showing a double-bottom signal and has been making headway trading up off of its lows for the past few sessions. We’ll want to monitor both of these plays into next week.

SPDR S&P 500 ETF (SPY) – Fresh Options Idea

It wouldn’t be a typical Friday without a end-of-week options idea, so we’re going to turn to one of our classic targets- the SPY. Here in the premarket we’ve observed a low of 207.58. How we’ll want to play it is this: Should the SPY maintain support at 207.50 or above on any early pullbacks, we’re going to be interested in the Weekly $207.50-208 Calls. In the event it fails to hold support a that point, we’ll look to the Weekly $208-207.50 Puts.

*CAUTION: Trading weekly options on Friday is commonly a very high risk proposition. To be attempted by advanced traders only!

Extended Watchlist:
SUNE, LNCO, LINE, VSLR, EBIX, DRWI, AXPW(Bottom-Watcher)

Blue Horseshoe Stocks: Options Review, Fresh Ideas & More

Wynn Resorts Ltd. WYNN – Options Review

It was the wide range of options contracts we highlighted in the WYNN chain that stole the show among our interests from yesterday morning’s premarket report.  We signaled the WYNN Weekly $93-96.50 Calls for observation, and not surprisingly, saw appreciable intraday gains from every single one of them.

Just take a look at the excellent single-session profits that were on the table for traders who fell in step with our idea. There was literally no way to go wrong with these selections, but at the top end of the range, the $96.50’s were obviously the star of the show with a nearly incomprehensible intraday move of more than 2700%!

$93 Calls – Trading Range: 2.98-7.68 – Max Gain: 158%
$93.50 Calls – Trading Range: 3.61-7.15 – Max Gain: 98%
$94 Calls– Trading Range: 2.53-6.20 – Max Gain: 145%
$94.50 Calls – Trading Range: 3.71-6.08 – Max Gain: 64%
$95 Calls – Trading Range: 2.40-5.62 – Max Gain: 134%
$95.50 Calls– Trading Range: 2.43-5.00 – Max Gain: 106%
$96 Calls – Trading Range: 1.47-5.00 – Max Gain: 240%
$96.50 Calls– Trading Range: .15-4.30 – Max Gain: 2766%

The stock is gapping up again this morning, so we expect the figures on these gains to be pushed even higher upon commencement of trading at the opening bell. We’ll also look for opportunities at a higher strike range with the $100-103 Calls as well.

Fresh Options Ideas

We’ve formulated a number of other options trading ideas to close out the week, but please heed our standard warning regarding Friday trading of weekly contracts- Only expert traders should attempt such a high-difficulty and risky venture. Both of the following are options chains from which we’ve pulled down mammoth gains on countless occasions in the past: 

SPDR S&P 500 ETF (SPY) – For the SPY, which of course is a general market analog, we’re going to be monitoring Weekly $205-207 Calls with both the general markets and oil gapping up this morning.

Petroleo Brasiliero S.A. (Petrobras) PBR – For PBR we’re zeroing in on the Weekly $5-6 Calls. PBR has made notable intraday upswings on more than one occasion this week, and a continuation of that pattern could lead to some nice gain figures for these contracts.

Extended Watchlist:
FRFS, MAXD, AVXL, AXAS, LEI, ORIG, SDRL, UWTI, WTI, BGMD(Bottom-bouncer)

Blue Horseshoe Stocks: Options Recap, Special Announcement & More

Successful Options Ideas

We formulated four sets of options trading ideas in yesterday morning’s premarket report, and it should come as no surprise to any of our readers apart from the very newest members, that all four ideas were winners. Gains were there for the taking regardless of which play struck people’s fancies.

SPDR S&P 500 ETF (SPY)

Our point of focus for the SPY yesterday morning was the SPY Weekly $204-206 Calls and those contracts provided not one, but two solid opportunities for intraday gains. The breakdown is as follows:

$204 Calls – 1st Run: 2.17-2.85 – Gained: 31%  – 2nd Run: 1.86-2.51 – Gained: 35%
$205 Calls – 1st Run: 1.36-1.96 – Gained: 31% – 2nd Run:  .96-1.61 – Gained: 68%
$206 Calls – 1st Run:  .67-1.14 – Gained: 70% – 2nd Run:  .40-.80 – Gained: 100%

_____

Apple, Inc. AAPL

Our highlighted range for AAPL, a stock whose options chain we taken advantage of too many times to count,was slated for AAPL Weekly $107-109 Calls.

$107 Calls – Trading Range: .1.79-3.45 – Max Gain: 98%
$108 Calls – Trading Range: 1.02-2.56 – Max Gain: 151%
$109 Calls – Trading Range:  .49-1.70 – Max Gain: 247%

_____

Lulu Lemon Athletica, Inc. LULU

We signaled LULU Weekly $62-65.50 Calls on the heels of the company’s earnings beat, and among those were some of the most solid intraday upswings we saw all day.

$62 Calls – Trading Range: 4.02-6.05 – Max Gain: 50%
$62.50 Calls – Trading Range:  3.10-5.85 – Max Gain: 89%
$65.50 Calls – Trading Range:  .82-2.50 – Max Gain: 205%

_____

Ambarella, Inc. AMBA

We were looking AMBA Weekly $44 and 46 Calls which ran hard out of the gate; traders would have had to have nimble fingers to extract the maximum profit on these ones inside of the session’s first ten minutes.

$44 Calls – Trading Range: 1.15-2.20 – Max Gain: 91%
$46 Calls – Trading Range:  .35-.90 – Max Gain: 157%

Blue Horseshoe Stocks to Present on the CannaInvestor Online Webcast

We’re proud to participate in the popular CannaInvestor Webcast, and invite all of our readers to check it out this afternoon! There will be a link you can visit on www.cannawebcast.com beginning today at 1pm Eastern. It’s a must-listen for any of our members who enjoy our coverage of the medical and legal marijuana space!

ROCHESTER, NY / ACCESSWIRE / March 31, 2016 / BlueHorseshoeStocks.com (BHS) is a blog-style website that offers a free daily stock alert newsletter to stock and options traders of all levels from beginning to advanced. Unlike your typical stock-picking service, BHS publishes a quality newsletter on a daily basis, giving its members a wide range of trading ideas including microcaps to big board stocks, options ideas and more.

For years, BHS has tracked and shared cannabis-related stock ideas with its readers, and enjoyed quite a bit of success in doing so. BHS is pleased to announce that it will present online on the CannaInvestor Webcast today Thursday, March 31, 2016 at 1:00 PM EDT – 1:45 PM EDT. (>>Full PR)

Potential Bottom-Play Watchlist
 
This morning we caught four different stocks trading at a bottom that we want to aggregate into a recovery watchlist. We’ll reserve some space on our radars for these plays in sessions to come, monitoring for any indication of a rebound for any of these plays:

RCPI, TWER, SKYS, UAMY

Extended Watchlist:
SFOR, ADMD, CPXX, GLBL, USLV, MNOV,
MDVN($41.50-43.50 Weekly Calls)

Blue Horseshoe Stocks: Fresh Options Ideas, VAPE Recap & More

Fresh Options Ideas

The markets made a notable upturn following yesterday’s Fed meeting from which we learned that it will be proceeding with caution regarding a potential interest rate hike. The floundering world economy as well as trouble with low inflation domestically were cited as reasons behind the reticence. Despite the note of uncertainty, there is nothing ambiguous about the overall market sentiment at present, which is leading us to formulate some bullish ideas on the options-trading front.

SPDR S&P 500 ETF (SPY)

We’ve enjoyed tons of success trading SPY options in the past when we need a close analog of the markets as a whole, so it stands to reason that we call out a new idea for some SPY Calls this morning. We’re going to be paying attention to the SPY Weekly $204-206 Calls.


Apple, Inc. AAPL

AAPL seemed to enjoy a boost in the wake of the US Government’s dismissal of the federal court case which had embroiled the two in recent weeks. After enjoying a steady increases throughout the session, the stock is currently gapping up in the premarket. Our target range here is going to be AAPL Weekly $107-109 Calls.

Ambarella, Inc. AMBA

We flagged AMBA in yesterday’s watchlist and it too produced a bullish session. In addition to being connected with AAPL being a provider of internal hardware for Apple devices, AMBA received an upgrade from analysts at Morgan Stanley. We’ve got a corresponding options idea for this one as well. For this play, we’re looking to the AMBA Weekly $44-46 Calls.

Lulu Lemon Athletica, Inc. LULU

LULU is gapping this morning on the heels of an earnings beat, so we’re going to want to signal some calls here as well. This is another stock whose options chain has provided us with ammunition for extreme gains in the past. We’ll be monitoring the LULU Weekly $62-65.50 Calls.

With everything gapping up in the premarket, we’ll of course be on the lookout for possible dip-and-rip scenarios prior to the execution of any of these ideas.

Vape Holdings, Inc. VAPE
 
We can officially add VAPE to the list of cannabis-related stocks that we’ve witnessed making appreciable upswings this week. We added it to yesterday’s morning report as another pot-play to keep an eye on, and we’re immediately rewarded with a solid opportunity for some single-session gains.

VAPE traded in a range from .0106 to .017 on the day, giving traders the chance at profits of up to 60% The move came in conjunction with the announcement of another round of debt restructuring and consolidation (>>View PR).

We’ve added new cannabis candidates to our radar each day this week, and we’ll repeat that again today, pinning CANL and MCOA to our watchlist.

Extended Watchlist:
RVUE, WDRP, EARI, GALE, ACAD

Blue Horseshoe Stocks: Options Review, Other Updates

Options Review

Just to refresh our readers’ memories, we highlighted a range of call contracts for three separate plays on Friday, and we’re pleased to report that sizable gains were there for the taking regardless of which idea was chosen. It marked the continuation of a flawless streak of such ideas that we offered up over the past few weeks.

Our tracked calls and the magnitude of the gains that were available were as follows:

SPDR S&P 500 (SPY) Weekly $199-202 Calls – We’ve successfully played the SPY so many times it doesn’t even bear counting, and Friday was no different. From the low end of our range to the high, gains of 80-427% were made.

Finisar Corp FNSR Weekly $15 and $16 Calls – An earnings beat made the gains in FNSR calls possible, with the $15’s running 88%, and the $16’s making a 92% upswing.

Ulta Salon, Cosmetics & Fragrance, Inc. ULTA  Weekly $175-185 Calls –  Last but not least, we had the ULTA contracts on our watchlist bank gains running from 59-117%

Again, it was yet another great week for options, and we’ll be doing everything in our power to keep the streak alive with some more ideas this week so be sure to stay tuned!

Friday’s Stock Gainers

In addition to our great success with options plays from Friday’s morning report, we had a number of other intraday movers which were also highlighted.

Propanc Health Group Corp. PPCH

This was our top-billed mention on Friday, having been following it for most of last week. A string of solid performances led the stock on a great intraweek run to that point which spanned from our observed low of .0188 to .037 (+97%) in just a few sessions.

We saw even more gains tacked on there during Friday’s trading, wherein we witnessed another nice intraday pop from the daily low of .0355 to .0516 (+45%), and the high extended our total observed range to an impressive 174% in a matter of four sessions.

_____

Mexus Gold US (MXSG)

Mexus was another point of discussion in Friday’s newsletter, and it too saw appreciable gains on the day.

We’d already been very familiar with the stock after tracking over a more than 1000% move in early February. We then re-tagged it the Wednesday before last and subsequently witnessed a 61% swing from .011-.018.

Friday’s session brought a continuation of that run from .017 to a high of .0299, a 71% intraday rip, and increased the total swing range to 172%

_____

Spectrascience, Inc. SCIE

SCIE was included in Friday’s tracklist and the stock would end up trading in a range from .003 to .0047, for total possible intraday gains of up to 56% on slightly heavier than normal volume.

It also managed to close just a tick below the high of day, so we’ll keep an eye peeled for the possibility of momentum spillover into this new trading week.

GW Pharmaceuticals, Inc. GWPH

We want to pin GWPH to our tracklist after catching a significant PR coming across the wires this morning. Late-stage studies on a cannabidiol (CBD) treatment of a rare pediatric disease has yielded positive results, and the stock has thus far gapped up over 100% in the premarket.

We’ll take our classic stance of monitoring for a possible dip-and-rip situation and look to get positioned in some in-the-money Calls, dependent upon where the bounce occurs.

LONDON, March 14, 2016 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (GWPH) (GWP.L) (“GW,” “the Company” or “the Group”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announces the positive results of the first pivotal Phase 3 study of its investigational medicine Epidiolex® (cannabidiol or CBD) for the treatment of Dravet syndrome. (>> FULL PR)

Extended Watchlist:
DDD, TFM, GBIM, HPTG, USAR, IEEC, ASTI, SVTE

Get Our FREE Daily Reports!

SUBSCRIBE